JP2019504899A5 - - Google Patents

Download PDF

Info

Publication number
JP2019504899A5
JP2019504899A5 JP2018561294A JP2018561294A JP2019504899A5 JP 2019504899 A5 JP2019504899 A5 JP 2019504899A5 JP 2018561294 A JP2018561294 A JP 2018561294A JP 2018561294 A JP2018561294 A JP 2018561294A JP 2019504899 A5 JP2019504899 A5 JP 2019504899A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
group
halogen
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018561294A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019504899A (ja
JP6849197B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2017/000040 external-priority patent/WO2017136871A1/en
Publication of JP2019504899A publication Critical patent/JP2019504899A/ja
Publication of JP2019504899A5 publication Critical patent/JP2019504899A5/ja
Application granted granted Critical
Publication of JP6849197B2 publication Critical patent/JP6849197B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018561294A 2016-02-12 2017-02-10 リジルオキシダーゼのインドールおよびアザインドールハロアリルアミン誘導体阻害剤およびその使用 Expired - Fee Related JP6849197B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2016900478 2016-02-12
AU2016900478A AU2016900478A0 (en) 2016-02-12 Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof
AU2016902593A AU2016902593A0 (en) 2016-07-01 Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof
AU2016902593 2016-07-01
PCT/AU2017/000040 WO2017136871A1 (en) 2016-02-12 2017-02-10 Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof

Publications (3)

Publication Number Publication Date
JP2019504899A JP2019504899A (ja) 2019-02-21
JP2019504899A5 true JP2019504899A5 (https=) 2020-03-26
JP6849197B2 JP6849197B2 (ja) 2021-03-24

Family

ID=59562850

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018561293A Active JP6843888B2 (ja) 2016-02-12 2017-02-10 リジルオキシダーゼのハロアリルアミンインドールおよびアザインドール誘導体阻害剤およびその使用
JP2018561294A Expired - Fee Related JP6849197B2 (ja) 2016-02-12 2017-02-10 リジルオキシダーゼのインドールおよびアザインドールハロアリルアミン誘導体阻害剤およびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018561293A Active JP6843888B2 (ja) 2016-02-12 2017-02-10 リジルオキシダーゼのハロアリルアミンインドールおよびアザインドール誘導体阻害剤およびその使用

Country Status (17)

Country Link
US (3) US10717734B2 (https=)
EP (2) EP3414226A4 (https=)
JP (2) JP6843888B2 (https=)
KR (2) KR102742235B1 (https=)
CN (2) CN109153642B (https=)
AU (2) AU2017217238B2 (https=)
BR (2) BR112018067442A8 (https=)
CA (2) CA3013850C (https=)
CO (2) CO2018009068A2 (https=)
EA (2) EA201891674A1 (https=)
IL (2) IL261118A (https=)
MX (1) MX388745B (https=)
PH (2) PH12018501686A1 (https=)
SG (2) SG11201806727TA (https=)
TW (2) TW201739454A (https=)
WO (2) WO2017136870A1 (https=)
ZA (2) ZA201805675B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201891674A1 (ru) 2016-02-12 2019-01-31 Фармаксис Лтд. Ингибиторы лизилоксидаз, представляющие собой индольные и азаиндольные производные галогеналлиламина, и их применения
EP3589619A4 (en) * 2017-03-02 2020-12-16 Pharmaxis Ltd. LYSYL OXIDASE INHIBITORS, HALOGENOALLYLAMINE PYRAZOLE DERIVATIVES AND THEIR USES
GB201716871D0 (en) 2017-10-13 2017-11-29 Inst Of Cancer Research: Royal Cancer Hospital Compounds
CN107903281B (zh) * 2017-10-27 2019-10-29 苏州大学 一种合成烷基硼酯化合物的方法
AR117398A1 (es) 2018-03-12 2021-08-04 Abbvie Inc Inhibidores de la señalización mediada por tirosina cinasa 2
KR20190110736A (ko) 2018-03-21 2019-10-01 주식회사유한양행 신규의 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
KR20190110740A (ko) 2018-03-21 2019-10-01 주식회사유한양행 신규의 아릴 또는 헤테로아릴 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
CN112533897B (zh) 2018-08-03 2023-07-14 法玛西斯有限公司 赖氨酰氧化酶的卤代烯丙胺砜衍生抑制剂及其用途
TW202039486A (zh) 2018-12-14 2020-11-01 南韓商柳韓洋行股份有限公司 三唑并吡啶-3-酮化物或其鹽及包含彼之醫藥組合物
TWI835945B (zh) 2018-12-14 2024-03-21 南韓商柳韓洋行股份有限公司 3,3-二氟烯丙胺化物或其鹽及包含彼的醫藥組合物
WO2020146639A2 (en) * 2019-01-11 2020-07-16 Viscient Biosciences, Inc. Compositions and methods for the diagnosis and treatment of diseases of the liver
WO2020161209A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
WO2020161208A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
JP2022544031A (ja) * 2019-07-25 2022-10-17 ファーマクシス リミテッド リシルオキシダーゼのジフルオロハロアリルアミンスルホン誘導体阻害剤、調製方法、及びそれらの使用
BR112022001488A2 (pt) 2019-07-29 2022-04-19 Heparegenix Gmbh Inibidores de proteínas quinases de pirazolo-piridina substituída com heteroarila para promover regeneração do fígado ou redução ou prevenção de morte de hepatócitos
CA3164361A1 (en) 2020-01-15 2021-07-22 Heparegenix Gmbh 3-benzoyl-1h-pyrrolo[2,3-b]pyridine derivatives as mkk4 inhibitors for treating liver diseases
US12578335B2 (en) 2020-02-05 2026-03-17 Syntara Limited Bioprobes for lysyl oxidases and uses thereof
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
WO2021261601A1 (ja) 2020-06-26 2021-12-30 ラクオリア創薬株式会社 レチノイドとがん治療薬との併用療法が有効ながん患者の選択方法およびレチノイドとがん治療薬との併用医薬
JP7384138B2 (ja) * 2020-09-30 2023-11-21 株式会社島津製作所 電気泳動装置
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
US20250066308A1 (en) * 2021-10-01 2025-02-27 Yuhan Corporation Bicyclic fused ring derivative or salt thereof and pharmaceutical composition comprising same
US12233056B2 (en) 2022-04-06 2025-02-25 Syntara Limited Lysyl oxidase inhibitors for treating myeloid malignancies
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
WO2024151519A2 (en) * 2023-01-09 2024-07-18 University Of Florida Research Foundatin, Incorporated Pparg modulators
CN117069611A (zh) * 2023-07-12 2023-11-17 浙江工业大学 一种1-(2,4,6-三氯苯基)丙-2-酮o-甲基肟的制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28819E (en) 1972-12-08 1976-05-18 Syntex (U.S.A.) Inc. Dialkylated glycol compositions and medicament preparations containing same
US4358603A (en) 1981-04-16 1982-11-09 Syntex (U.S.A.) Inc. Acetal stabilized prostaglandin compositions
US4454158A (en) 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4699928A (en) 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
US4965288A (en) 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5059714A (en) 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5021456A (en) 1988-02-25 1991-06-04 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5182297A (en) 1988-02-25 1993-01-26 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4943593A (en) * 1988-02-25 1990-07-24 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5252608A (en) 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4997854A (en) * 1989-08-25 1991-03-05 Trustees Of Boston University Anti-fibrotic agents and methods for inhibiting the activity of lysyl oxidase in-situ using adjacently positioned diamine analogue substrates
WO2004018997A2 (en) 2002-08-20 2004-03-04 Neurogenetics, Inc. Methods and compositions for modulating amyloid beta
US9161922B2 (en) * 2005-07-01 2015-10-20 Case Western Reserve University Amine oxidase inhibitors
US20070293548A1 (en) 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
US20080293936A1 (en) 2007-05-23 2008-11-27 Elmar Reinhold Burchardt Novel inhibitors of lysyl oxidase
AU2014200520A1 (en) * 2007-08-02 2014-02-20 Gilead Biologics, Inc. Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
ES2700141T3 (es) * 2007-08-02 2019-02-14 Gilead Biologics Inc Anticuerpos inhibidores LOXL2 y usos de los mismos
CA2705303A1 (en) * 2007-11-07 2009-05-14 Foldrx Pharmaceuticals, Inc. Modulation of protein trafficking
CN101917845A (zh) * 2007-11-21 2010-12-15 法马克西斯制药公司 Ssao/vap-1的卤代烯丙胺抑制剂及其用途
US8569512B2 (en) * 2009-03-23 2013-10-29 Merck Sharp & Dohme Corp. P2X3 receptor antagonists for treatment of pain
WO2011022670A1 (en) 2009-08-21 2011-02-24 Arresto Biosciences, Inc In vivo screening assays
US8841463B2 (en) * 2011-02-11 2014-09-23 Glaxosmithkline Intellectual Property Development Limited Cathepsin C inhibitors
AU2013255103B2 (en) * 2012-05-02 2016-09-29 Syntara Limited Substituted 3-haloallylamine inhibitors of SSAO and uses thereof
KR102494596B1 (ko) * 2014-07-31 2023-01-31 재단법인 한국파스퇴르연구소 2-아미노-벤즈이미다졸 유도체 및 5-리폭시게나아제 및/또는 프로스타글란딘 e 합성효소 억제제로서의 이들의 용도
EA201891674A1 (ru) 2016-02-12 2019-01-31 Фармаксис Лтд. Ингибиторы лизилоксидаз, представляющие собой индольные и азаиндольные производные галогеналлиламина, и их применения

Similar Documents

Publication Publication Date Title
JP2019504899A5 (https=)
JP2019504898A5 (https=)
JP2016520618A5 (https=)
JP2004513882A5 (https=)
JP2017528467A5 (https=)
JP2014520823A5 (https=)
JP2013518050A5 (https=)
JP2019537557A5 (https=)
JP2020510664A5 (https=)
JP2011526924A5 (https=)
JP2008535903A5 (https=)
JP2022533069A5 (https=)
JP2010526814A5 (https=)
JP2017132814A5 (https=)
JP2010511626A5 (https=)
JP2009524691A5 (https=)
JP2013523802A5 (https=)
JP2011527666A5 (https=)
JP2022553702A5 (https=)
JP2021512114A5 (https=)
JP2013516480A5 (https=)
JP2008543860A5 (https=)
JP2017522348A5 (https=)
JP2008546770A5 (https=)
JP2021535087A5 (https=)